Clinical Trials Directory

Trials / Conditions / Differentiated Thyroid Cancer (DTC)

Differentiated Thyroid Cancer (DTC)

8 registered clinical trials studyying Differentiated Thyroid Cancer (DTC) — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingDecision Aid Efficacy in Low Risk Thyroid Cancer
NCT07536412
University of Maryland, BaltimoreN/A
RecruitingThe EMIRATES Study
NCT06855680
Royal Marsden NHS Foundation Trust—
Active Not RecruitingStudy of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With
NCT04940052
Novartis PharmaceuticalsPhase 3
CompletedRobotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With
NCT07229859
Ruijin Hospital—
CompletedA Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China
NCT02966093
Eisai Co., Ltd.Phase 3
CompletedStudy of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adult
NCT02432274
Eisai LimitedPhase 1 / Phase 2
CompletedNintedanib(BIBF1120) in Thyroid Cancer
NCT01788982
European Organisation for Research and Treatment of Cancer - EORTCPhase 2
UnknownA Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carc
NCT02041260
Thomas Jefferson UniversityPhase 2